4ed0bea5-figure-01 (4ed0bea5 Figure 01)
Tizanidine
Product Images NDC 58517-380
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 58517-380). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
4ed0bea5-figure-02 (4ed0bea5 Figure 02)
Plasma tizanidine concentration can be measured in ng/mL after ingesting different formulations of 4 mg tizanidine tablets or capsules with or without food. The data is presented in a table with time (hours from dosing) and different letters indicating the treatment groups. No further information is provided.*
4ed0bea5-figure-03 (4ed0bea5 Figure 03)
4ed0bea5-figure-04 (4ed0bea5 Figure 04)
4ed0bea5-figure-05 (4ed0bea5 Figure 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
